Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia

Cited by (271)

Items 101–200 of 271

1. Simple acute phase protein score to predict long‐term survival in patients with acute myeloid leukemia
   Alexander D. Heini, Rebecca Hugo, Martin D. Berger, Urban Novak, Ulrike Bacher, Thomas Pabst · 2019 · Hematological Oncology
2. Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
   Fangmin Zhong, Fangyi Yao, Jing Liu, Haibin Zhang, Jing Zhang, Nan Zhang, Lin Jin, Shuqi Li, Mei‐Yong Li, Junyao Jiang et al. · 2022 · Frontiers in Oncology
3. Rescue of cardiac dysfunction during chemotherapy in acute myeloid leukaemia by blocking IL-1α
   Xingliang Zhou, Yiwei Liu, Yi Shen, Lijun Chen, Wenting Hu, Yi Yan, Bei Feng, Li Xiang, Yifan Zhu, Chenyu Jiang et al. · 2024 · European Heart Journal
4. Joint representation and visualization of derailed cell states with Decipher
   Achille Nazaret, Joy Linyue Fan, Vincent‐Philippe Lavallée, Cassandra Burdziak, Andrew E. Cornish, Vaidotas Kiseliovas, Robert L. Bowman, Ignas Masilionis, Jaeyoung Chun, Shira Esther Eisman et al. · 2025 · Genome biology
5. ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS
   Helong Zhao, Michael W. Deininger · 2023 · Blood
6. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
   Manuel Mendes, Ana Carolina Monteiro, Estrela Neto, Cristina Carvalho Barrias, Manuel Sobrinho Simões, Delfim Duarte, Hugo R. Caires · 2024 · International Journal of Molecular Sciences
7. IL-37 Was Involved in Progress of Acute Myeloid Leukemia Through Regulating IL-6 Expression
   Xiaonan Wei, Yulan Li, Guili Zhang, Na Wang, Miaomiao Mi, Yu Xin, Huihui Jiang, Chengming Sun · 2021 · Cancer Management and Research
8. Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL
   P. Bruch, Holly A. R. Giles, C. Kolb, S. Herbst, Tina Becirovic, T. Roider, Jun-Yan Lu, S. Scheinost, L. Wagner, J. Huellein et al. · 2022 · Molecular Systems Biology
9. A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemia
   Basil Allen, Daniel Bottomly, Thomas Köhnke, Anthony Wang, Hsin‐Yun Lin, Kara J. Johnson, Isabel Kenna, Anastatia Streltsova, Emma Martin, Reid Chen et al. · 2025 · Blood
10. LILRB3 as a regulator of AML survival
    Audrey Lasry, Iannis Aifantis · 2021 · Nature Cancer
11. Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
    Petter S. Woll, Tetsuichi Yoshizato, Eva Hellström‐Lindberg, Thoas Fioretos, Benjamin L. Ebert, Sten Eirik W. Jacobsen · 2022 · Journal of Internal Medicine
12. Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks
    Mabel Minji Jung, Siqi Shen, Giovanni A. Botten, Thomas Olender, Koichi Ricardo Katsumura, Kirby D. Johnson, Alexandra A. Soukup, Peng Liu, Qingzhou Zhang, Zena D. Jensvold et al. · 2023 · Journal of Clinical Investigation
13. Chronic inflammation can transform the fate of normal and mutant hematopoietic stem cells
    Jingjing Li, Camille Malouf, Linde A. Miles, M Willis, Eric Martin Pietras, Katherine Y. King · 2023 · Experimental Hematology
14. Protein–ligand interaction fingerprints for accurate prediction of dissociation rates of p38 MAPK Type II inhibitors
    Duo Zhang, Shuheng Huang, Mei Ying Hu, MuliadiYeremia Kevin, Tingting Shi, Linxin Chen · 2019 · Integrative Biology
15. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche
    Yuxia Wang, Xiaolu Sun, Shengnan Yuan, Shuaibing Hou, Tengxiao Guo, Yajing Chu, Tianxiang Pang, Hongbo Robert Luo, Weiping Yuan, Xiaomin Wang · 2020 · Cytotherapy
16. Necroinflammation emerges as a key regulator of hematopoiesis in health and disease
    Philipp Jakob Jost, Ulrike Höckendorf · 2018 · Cell Death and Differentiation
17. A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia
    Pierre Péterlin, Joëlle Gaschet, Thierry Guillaume, Alice Garnier, Marion Eveillard, Amandine Le Bourgeois, Michel Chérel, Camille Debord, Yannick Le Bris, Olivier Theisen et al. · 2020 · Cancer Medicine
18. Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
    Victoria Stavrou, Livingstone Fultang, Sarah Booth, Daniele De Simone, Arekdiusz Bartnik, Ugo Scarpa, Luciana Gneo, Silvia Panetti, Sandeep Potluri, Meaad Almowaled et al. · 2022 · Cancer Immunology Immunotherapy
19. Progress toward Better Treatment of Therapy-Related AML
    Angeliki Kotsiafti, Konstantinos Giannakas, Panagiotis Christoforou, Konstantinos Liapis · 2023 · Cancers
20. Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals
    Noémie Ravalet, Hélène Guermouche, Pierre Hirsch, Frédéric Picou, Amélie Foucault, Nathalie Gallay, Jean‐Alain Martignoles, Jenny Beaud, Ludovic Suner, Caroline Deswarte et al. · 2023 · Clinical Immunology
21. Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia
    Rucha V. Modak, Katia G. de Oliveira Rebola, John McClatchy, Mona Mohammadhosseini, Alisa Damnernsawad, Stephen E. Kurtz, Christopher A. Eide, Guanming Wu, Ted Laderas, Tamilla Nechiporuk et al. · 2024 · Clinical Cancer Research
22. Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression
    Valentina R. Minciacchi, Christina Karantanou, Jimena Bravo, Raquel S. Pereira, Costanza Zanetti, Theresa Krack, Rahul Kumar, Katrin Bankov, Sylvia Hartmann, Brian J.P. Huntly et al. · 2024 · Blood Advances
23. The Capacity of Long-Term In Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome
    Annette K. Brenner, Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode S. Berven, Ida-Sofie Grønningsæter, Sushma Bartaula-Brevik, Øystein Bruserud · 2019 · Cancers
24. Inhibition of interleukin‐1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis
    Dragana Dragoljevic, Man K.S. Lee, Cynthia Louis, Waled Shihata, Michael James Kraakman, Jacinta A Hansen, Seth Lucian Masters, Beatriz Yae Hanaoka, Prabhakara R. Nagareddy, Graeme Iain Lancaster et al. · 2020 · Clinical & Translational Immunology
25. The rewired immune microenvironment in leukemia
    Zoe B. Ciantra, Varvara Paraskevopoulou, Iannis Aifantis · 2025 · Nature Immunology
26. Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia
    Mohammed Alasseiri, Afsar U. Ahmed, Bryan R.G. Williams · 2018 · Cytokine & Growth Factor Reviews
27. Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
    Stephen E. Kurtz, Christopher A. Eide, Andy J. Kaempf, Nicola Long, Daniel Bottomly, Olga H. Nikolova, Brian J. Druker, Shannon K. McWeeney, Bill H. Chang, Jeffrey W Tyner et al. · 2022 · Blood Advances
28. Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors
    Chengjing Zhou, Rizvan C Uluisik, Jesse W. Rowley, Camille David, Courtney L. Jones, Christopher D. Scharer, Leila J. Noetzli, Marlie H. Fisher, Gregory D. Kirkpatrick, Katrina Bark et al. · 2022 · Experimental Hematology
29. Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics
    Cristina E. Tognon, Rosalie C. Sears, Gordon Brent Mills, Joe W. Gray, Jeffrey W Tyner · 2020 · Annual Review of Cancer Biology
30. Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
    Nicola Daniele Andina, Nicolas Bonadies, Ramanjaneyulu Allam · 2022 · Frontiers in Cell and Developmental Biology
31. PU.1 is required to restrain myelopoiesis during chronic inflammatory stress
    Chavez, James S., Rabe, Jennifer L., Niño, Katia E., Wells, Harrison H., Gessner, Rachel L., Mills, Taylor S., Hernandez, Giovanny, Pietras, Eric M. · 2023 · Frontiers in Cell and Developmental Biology
32. Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes
    Hamid Bolouri, Rhonda E. Ries, ALICE E. WIEDEMAN, Tiffany Hylkema, Sheila Scheiding, Vivian H. Gersuk, Kimberly O’Brien, Quynh-Anh Nguyen, Jenny L. Smith, Sarah Alice Long et al. · 2022 · Nature Communications
33. Emerging Insights into Molecular Mechanisms of Inflammation in Myelodysplastic Syndromes
    Veronica Vallelonga, Francesco Gandolfi, Francesca Ficara, Matteo Giovanni Della Porta, Serena Ghisletti · 2023 · Biomedicines
34. Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia
    Mirazul Islam, Elsa Haniffah Mejia Mohamed, Ezalia Esa, Nor Rizan Kamaluddin, Shamsul Mohd Zain, Yuslina Mat Yusoff, Yassen Assenov, Zahurin Mohamed, Zubaidah Zakaria · 2017 · British Journal of Cancer
35. Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches
    Jean-Pierre Lévesque, KIM M. SUMMERS, Susan Marie Millard, Kavita Bisht, Ingrid G. Winkler, Allison Robyn Pettit · 2021 · Experimental Hematology
36. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance
    Tassadit Belabbas, Takaaki Yamada, Nobuaki Egashira, Takeshi Hirota, Kimitaka Suetsugu, Yasuo Mori, Koji Kato, Koichi Akashi, Ichiro Ieiri · 2023 · Journal of Infection and Chemotherapy
37. RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition
    Amy C. Fan, Yusuke Nakauchi, Lawrence Bai, Armon Azizi, Kevin A. Nuno, Feifei Zhao, Thomas Köhnke, Daiki Karigane, David Cruz Hernandez, Andreas Reinisch et al. · 2023 · Journal of Clinical Investigation
38. The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis
    Nozomu Kawashima, Valentino Bezzerri, Seth Joel Corey · 2023 · Biomolecules
39. The roles and mechanisms of TGFB1 in acute myeloid leukemia chemoresistance
    Xue Liang, Ji Zhou, Cong Li, Huiping Wang, Yang Wan, Chun Ling, Lianfang Pu, Wanqiu Zhang, Mengmeng Fan, Jingfang Hong et al. · 2024 · Cellular Signalling
40. Microtransplantation in older patients with AML : A pilot study of safety, efficacy and immunologic effects
    Anthony Derek Sung, Shekeab Jauhari, Sharareh Siamakpour‐Reihani, Arati V. Rao, Janet S. Staats, Cliburn C. W. Chan, Everett H. Meyer, Vijayakrishna K. Gadi, Andrew B. Nixon, Jing Lyu et al. · 2020 · American Journal of Hematology
41. IL-33-dependent NF-κB activation inhibits apoptosis and drives chemoresistance in acute myeloid leukemia
    Muxia Yan, Xuexin Chen, Qian Ye, Huating Li, Li Zhang, Yiqian Wang · 2024 · Cytokine
42. Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis
    Michela Luciano, Helene Sieberer, Peter William Krenn, Hieu-Hoa Dang, Julia Vetter, Theresa Neuper, Diana Amend, Constantin Blöchl, Christian X. Weichenberger, Anna Eglseer et al. · 2024 · Cell Communication and Signaling
43. CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia
    Paul Deschamps, Margaux Wacheux, Axel Gosseye, Margot Morabito, Arnaud Pagès, Anne-Marie Lyne, Alexia Alfaro, Philippe Rameau, Aygun Imanci, Rabie Chelbi et al. · 2024 · Journal of Clinical Investigation
44. Leukemic IL‐17RB signaling regulates leukemic survival and chemoresistance
    He‐Zhou Guo, Li‐Ting Niu, Wanting Qiang, Juan Chen, Juan Wang, Hui Yang, Wu Zhang, Jiang Zhu, Shanhe Yu · 2019 · The FASEB Journal
45. Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia
    Kathryn I. Sunthankar, Matthew T. Jenkins, Candace H. Cote, Sweta B. Patel, Robert S. Welner, Paul Brent Ferrell · 2021 · Leukemia
46. Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome
    Michael James Kraakman, Hélène L. Kammoun, Dragana Dragoljevic, Annas Al‐Sharea, Man K.S. Lee, Michelle Flynn, C Stolz, Andrew A. Guirguis, Graeme Iain Lancaster, Jaye P.F. Chin-Dusting et al. · 2018 · Haematologica
47. The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β–mediated AML progression
    Hsin‐Yun Lin, Mona Mohammadhosseini, John McClatchy, Marina Villamor-Payà, Sophia Jeng, Daniel Bottomly, Chia‐Feng Tsai, Camilo Posso, Jeremy Jacobson, Andrew Adey et al. · 2024 · Blood
48. Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway
    Denggang Fu, Hua Jiang, Alan Long, Ella Harris, Hong-Fen Guo, Maegan L. Capitano, John M. Wrangle, Joshua R. Faust, Anilkumar Gopalakrishnapillai, Santhosh Kumar Pasupuleti et al. · 2025 · Nature Communications
49. Research progress on exosomes derived from mesenchymal stem cells in hematological malignancies
    Tianxin Lyu, Binglei Zhang, Mengjia Li, Xueli Jiao, Yongping Song · 2020 · Hematological Oncology
50. Inflammatory response mediates cross-talk with immune function and reveals clinical features in acute myeloid leukemia
    Fang-Min Zhong, Fang-Yi Yao, Jing Liu, Hai-Bin Zhang, Mei-Yong Li, Jun-Yao Jiang, Yan-Mei Xu, Wei-Ming Yang, Shu-Qi Li, Jing Zhang et al. · 2022 · Bioscience Reports
51. A statistical network pre-processing method to improve relevance and significance of gene lists in microarray gene expression studies
    Giuseppe Agapito, Marianna Milano, Mario Cannataro · 2022 · BMC Bioinformatics
52. Poly(ferulic acid) nanocarrier enhances chemotherapy sensitivity of acute myeloid leukemia by selectively targeting inflammatory macrophages
    Weijian Zhang, Xianyu Deng, Liying Wang, Jian Wang, Xiuting Guo, Lianggui Huang, Xinyi Wang, Jun Wu, Linjia Jiang · 2023 · Chinese Chemical Letters
53. Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges
    Anup Singh Pathania · 2024 · Cancers
54. IL-1β Induces SOCS2 Expression in Human Dendritic Cells
    Muamera Sarajlic, Theresa Neuper, Kim Tamara Föhrenbach Quiroz, Sara Michelini, Julia Vetter, Susanne Schaller, Jutta Horejs‐Hoeck · 2019 · International Journal of Molecular Sciences
55. Inflammatory signaling in the pathogenesis of acute myeloid leukemia
    Artemis Baumann, Jana M. Ellegast · 2025 · HemaSphere
56. Regulation of Interleukin-36γ/IL-36R Signaling Axis by PIN1 in Epithelial Cell Transformation and Breast Tumorigenesis
    Muna Poudel, Poshan Yugal Bhattarai, Pratikshya Shrestha, Hong Seok Choi · 2022 · Cancers
57. Leukemic progenitor cells enable immunosuppression and post-chemotherapy relapse via IL-36–inflammatory monocyte axis
    He‐Zhou Guo, Zi-hua Guo, Shanhe Yu, Li‐Ting Niu, Wanting Qiang, Mengmeng Huang, Yuanyuan Tian, Juan Chen, Hui Yang, Xiangqin Weng et al. · 2021 · Science Advances
58. Prognostic implications of cGAS and STING gene expression in acute myeloid leukemia
    Qiuling Chen, Yan Hong, Weifeng Chen, Feng Lin, Jiawei Zeng, Yueting Huang, Li Zhang, Jingwei Yao, Bing Xu · 2024 · Experimental Biology and Medicine
59. JAK-STAT-activated, fratricide-resistant CAR-T cells targeting membrane-bound TNF effectively treat AML and solid tumors
    Takahiro Nakashima, Tsunenori Ouchida, Yuichi Ishikawa, Yusuke Ito, Taeko Hayakawa, Toshiaki Yoshikawa, Haosong Zhang, Hitomi Kasuya, Yang Li, Tetsuya Matsukawa et al. · 2025 · Journal for ImmunoTherapy of Cancer
60. Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment
    Sisi Chen, Sergio Barajas, Sasidhar Vemula, Yuxia Yang, Edward R. Simpson, Hongyu Gao, Rudong Li, Farzaneh Behzadnia, Sarah C. Nabinger, David A. Schmitz et al. · 2025 · Journal of Clinical Investigation
61. Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
    Paul Dowling, Ciara Tierney, Katie Dunphy, Juho Jalmari Miettinen, Caroline Akemi Heckman, Despina Bazou, Peter O’Gorman · 2021 · Proteomes
62. Immunotherapeutic potential of ethanolic olive leaves extract (EOLE) and IL-28B combination therapy in ENU induced animal model of leukemia
    Priyatosh Nath, Debabrata Majumder, Rahul Debnath, Mousumi Debnath, Surinder Singh Sekhawat, Debasish Maiti · 2022 · Cytokine
63. Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency
    Patrick Flynn, Mark D. Long, Yoko Kosaka, Nicola Long, Jessica S. Mulkey, Jesse L. Coy, Anupriya Agarwal, Evan F. Lind · 2024 · Frontiers in Immunology
64. IL‐1Ra protects hematopoietic cells from chemotoxicity through p53‐induced quiescence
    Hao Ye, Lan Qian, Shunying Zhu, Shaorong Deng, Xia Wang, Jiang Zhu, Gerald L. Chan, Yan Yu, Wei Han · 2019 · The FASEB Journal
65. Microcapillary Array-Based High Throughput Screening for Protein Biomanufacturability
    Khushank Singhal, Harry E. Adamson, Thomas M. Baer, Howard M. Salis, Melik C. Demirel · 2025 · ACS Synthetic Biology
66. Mutant IDH1 cooperates with NPM1c or FLT3 ITD to drive distinct myeloid diseases and molecular outcomes
    Takashi Sakamoto, Julie Leca, Xin Zhang, Cem Meydan, Jonathan Foox, Parameswaran Ramachandran, Liam D. Hendrikse, Wenjing Zhou, Thorsten Berger, Jérôme Fortin et al. · 2025 · Proceedings of the National Academy of Sciences
67. Role of interleukins in acute myeloid leukemia
    Yin Wang, Xiao Jun Tang, Yu Zhu, Xiaoxiao Yang, Bei Liu · 2023 · Leukemia & lymphoma/Leukemia and lymphoma
68. Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy
    Rui Hu, Xiaosui Ling, Tonghua Yang, Jinping Zhang, Xuezhong Gu, Fan Li, Heng Chen, Yan Wen, Zengzheng Li, Yunlian Zou et al. · 2023 · Clinical and Experimental Medicine
69. Autophagy and inflammasome activation are associated with poor response to FLT3 inhibitors in patients with FLT3-ITD acute myeloid leukemia
    BGS Macedo, Manuela Albuquerque de Melo, Diego A. Pereira‐Martins, João Agostinho Machado‐Neto, Fabı́ola Traina · 2024 · Scientific Reports
70. Identification of PANoptosis-based signature for predicting the prognosis and immunotherapy response in AML
    Lu Zhang, Yanan Yu, Guiqing Li, Jiachun Li, Xiaolin Ma, Jiao Ren, Na Liu, Songyue Guo, Jinwei Cai, Jinwei Cai · 2024 · Heliyon
71. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia
    Lingling Shi, Rui Huang, Yongrong Lai · 2021 · BMC Medical Genomics
72. Analyzing signaling activity and function in hematopoietic cells
    Tobías Kull, Timm Schroeder · 2021 · The Journal of Experimental Medicine
73. Directional capacity of human mesenchymal stem cells to support hematopoietic stem cell proliferation in vitro
    Mohadese Hashem Boroojerdi, Vahid Hosseinpour Sarmadi, Maryam Maqbool, King‐Hwa Ling, Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Rajesh Ramasamy · 2022 · Gene
74. Serum levels of selected cytokines and soluble adhesion molecules in acute myeloid leukemia: Soluble receptor for interleukin-2 predicts overall survival
    Tomáš Kupsa, Jan Vanek, Павел Зак, Ladislav Jebavý, Jan M. Horáček · 2020 · Cytokine
75. Innate immune-inflammatory signaling milieu in myeloid leukemia and aging-associated clonal hematopoiesis pathologies
    Satyaki Bhowmik, Anwesha Bose, Amitava Sengupta · 2025 · Frontiers in Immunology
76. Inflammation in Myeloid Malignancies: From Bench to Bedside
    Eli M. Soyfer, Angela G. Fleischman · 2021 · Journal of Immunotherapy and Precision Oncology
77. Metabolic reprogramming of fetal hematopoietic stem and progenitor cells by maternal obesity
    Oleg Varlamov · 2025 · Frontiers in Hematology
78. Target practice: Opportunities for therapeutic intervention in CHIP and CCUS
    Ayman Mohammad, John O Mascarenhas, Bridget Kelly Marcellino, Daniel I. Nathan · 2025 · Blood Reviews
79. Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia
    Abhishek Dhawan, Eric Padron · 2021 · Current Opinion in Hematology
80. Predictive values of plasma TNFα and IL-8 for intracranial hemorrhage in patients with acute promyelocytic leukemia
    Fangyi Dong, Li Chen, Chaoxian Zhao, Xiaoyang Li, Yun Tan, Huan Song, Wen Jin, Hongming Zhu, Yunxiang Zhang, Kai Xue et al. · 2022 · Frontiers of Medicine
81. SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
    Ewan Selkirk, Rahima Patel, Anna Hoyle, Michael Lie‐A‐Ling, Duncan L. Smith, Joe Swift, Georges Lacaud · 2022 · Heliyon
82. Mutant C/EBPα p30 alleviates immunosuppression of CD8+ T cells by inhibiting autophagy‐associated secretion of IL‐1β in AML
    Jundan Wang, Jue‐Qiong Xu, Xuening Zhang, Ze‐Wei Huang, Lingling Liu, Ling Zhang, Xinxing Lei, Man‐Jie Xue, Jianyu Weng, Zi‐Jie Long · 2022 · Cell Proliferation
83. IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities
    Alessandra Mortellaro, Sara Mastaglio, Marta Muzio · 2025 · Cellular and Molecular Life Sciences
84. A comprehensive analysis of cell‐autonomous and non‐cell‐autonomous regulation of myeloid leukemic cells: The prospect of developing novel niche‐targeting therapies
    Shalmali Pendse, Sayali Chavan, Vaijayanti Prakash Kale, Anuradha Vaidya · 2023 · Cell Biology International
85. Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia
    Verónica Alonso-Pérez, Klaudia Galant, Fabien Boudia, Elie Robert, Zakia Aid, Laurent Renou, Vilma Barroca, Saryiami Devanand, Loélia Babin, V. Rouiller et al. · 2024 · Molecular Cancer
86. Targeting IL-1/IRAK1/4 signaling in acute myeloid leukemia stem cells following treatment and relapse
    Tzu‐Chieh Ho, Mark W. LaMere, Hiroki Kawano, Daniel K. Byun, Elizabeth A. LaMere, Yu‐Chiao Chiu, Chunmo Chen, Li‐Ju Wang, Jian Wang, Baskar Ramdas et al. · 2025 · Leukemia
87. [Retracted] High‐Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA)
    Ling Kui, Min Li, Xiaonan Yang, Ling Mei Yang, Qinghua Kong, Yunbing Pan, Zetan Xu, Shouling Wang, Dan-Dan Mo, Yang Dong et al. · 2021 · BioMed Research International · Retracted
88. High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort
    Guillaume Richard‐Carpentier, François Béliveau, Sandrine Lacoste, Banafsheh Khakipoor, Véronique Lisi, Michael Vladovsky, Miriam Marquis, Jean-François Spinella, Patrick Gendron, Sébastien Lemieux et al. · 2025 · Biomarker Research
89. Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia
    Suellen L. R. Silva, Gabriela A. da C. Barbosa, João V.B. Rios, Daniel Pereira Bezerra · 2026 · Biomedicine & Pharmacotherapy
90. Studying Signaling Pathway Activation in TRAIL-Resistant Macrophage-Like Acute Myeloid Leukemia Cells
    Yana V. Lomovskaya, K. S. Krasnov, M. I. Kobyakova, Anastasia A. Kolotova, Artem M. Ermakov, А. С. Сенотов, Irina S. Fadeeva, E. I. Fetisova, A. I. Lomovsky, A. I. Zvyagina et al. · 2024 · Acta Naturae
91. Immunomodulatory and Anticancer Effects of Fridericia chica Extract-Loaded Nanocapsules in Myeloid Leukemia
    Alice de Freitas Gomes, Adriane Dâmares de Sousa Jorge Batalha, Carlos Eduardo de Castro Alves, Renata Galvão de Azevedo, Jesús Rafael Rodríguez Amado, Tatiane Pereira de Souza, Héctor H. F. Koolen, Felipe M. A. da Silva, Francisco Célio Maia Chaves, Serafim Florentino Neto et al. · 2024 · Pharmaceutics
92. Inhibition of NLRP3 enhances pro-apoptotic effects of FLT3 inhibition in AML
    Helene Sieberer, Michela Luciano, Diana Amend, Constantin Blöchl, Anna Eglseer, Alina Steinkellner, Sebastian Rieser, Ancuela Andosch, Philip Steiner, Laura Hummer et al. · 2025 · Cell Communication and Signaling
93. Shared genetic association between inflammatory bowel disease and acute myeloid leukemia: insights from mendelian randomization and transcriptomic analyses
    Yanqun Zhou, Xiongfeng Zhang, Shangjin Yin, Yuhong Yao, Tao Chen, Liming Huang, Zenghui Liu · 2025 · Inflammation Research
94. The discussion on the differences in immune microenvironment between low-risk and high-risk myelodysplastic syndromes and acute myeloid leukemia
    Yinglong Wang, Xinhua Xiao, Hanxue Zheng, Jun Yuan Bai, Lijuan Li, Liansheng Zhang · 2025 · Leukemia & lymphoma/Leukemia and lymphoma
95. A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis
    Vanessa S. Morris, Hanya Ghazi, Daniel M. Fletcher, Barbara‐ann Guinn · 2023 · International Journal of Molecular Sciences
96. Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation
    Sandro Trova, Fei Lin, Santosh Kumar Lomada, Matthew Fenton, Bhavini Chauhan, Alexandra Adams, Avani Puri, Alessandro Di Maio, Thomas Wieland, Daniel Sewell et al. · 2023 · PLoS ONE
97. Cellular and immunotherapies for myelodysplastic syndromes
    Ryan J. Stubbins, Hannah Marie Cherniawsky, Aly Karsan · 2024 · Seminars in Hematology
98. Galectin-9 induces IL-1β production as a key inflammatory cytokine in the acute myeloid leukemia cell line (U937)
    Nafiseh Behranvand, Farzad Nasri, Maryam Vakily Moghaddam, Mohammad Davoodzadeh Gholami, Elahe Safari, Nafiseh Esmaeil, Reza Falak · 2025 · Research in Pharmaceutical Sciences
99. Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor
    Šárka Němečková, Kamila Žůrková, Petr Hainz, Jitka Kryštofová, Jana Macková, K Roubalová, Markéta Šťastná-Marková, Milena Vraná, Jan Vydra · 2022 · Current Oncology
100. Clodronate-liposomes aggravate irradiation-induced myelosuppression by promoting myeloid differentiation
     Wen Ju, Wenyi Lu, Yurong Bao, Tiantian Sun, Seyram Yao Adzraku, Chunling Fu, Kunming Qi, Xi Zhang, Zhenyu Li, Kailin Xu et al. · 2020 · International Journal of Radiation Biology